DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Estée Lauder Opens AI-Driven “Fragrance Atelier” in Paris
On October 14, The Estée Lauder Companies Inc. announced the opening of its new hub, La Maison des Parfums, on Rue Volney in Paris’s 2nd arrondissement. At the heart of this new facility lies the Fragrance Atelier, an advanced research and innovation center that marks a major step in the company’s commitment to the future of perfumery.
Launched under the high patronage of French President Emmanuel Macron, the Paris flagship serves as a global innovation hub designed to accelerate Estée Lauder’s growth in the luxury and prestige fragrance sectors.
Cosmo International Fragrances and Doctor Aromas form partnership to ‘transform aerosol fragrance delivery’
Cosmo International Fragrances and Doctor Aromas have announced a strategic partnership to develop Everspray™ technology, a next-generation aerosol system set to revolutionise fragrance delivery.
The collaboration combines Everspray’s patented aerosol innovation with Cosmo’s expertise in fragrance formulation and creation, promising superior aerosol products with enhanced suspension, long-lasting performance, and fragrance concentrations of up to 40%.
Everspray represents a breakthrough in fragrance diffusion, producing micro-droplets that remain suspended in the air 10 to 100 times longer than traditional aerosols.
The technology delivers a more powerful and enduring olfactory experience, extended diffusion, and leaves no residue on floors.
Already recognised by the industry, Everspray recently received the SATA Innovation Award for Advancement in Formulation, highlighting its cutting-edge approach to aerosol science and delivery systems.
Designed with safety and sustainability in mind, Everspray™ is alcohol-free, non-flammable, and has a low global warming potential (GWP), offering a cleaner, safer solution for both people and the planet.
Marc Blaison, President of Cosmo International Fragrances, commented: "This partnership reflects our commitment to pushing fragrance innovation into new territory. By combining Cosmo’s expertise with Everspray’s cutting-edge technology, we are creating smarter, safer, and more sensorial aerosol experiences for our clients."
Tears could open new avenue for diagnosing and monitoring eye and neurodegenerative diseases
Ocular fluids provide a window into the health of the eye and the development of various pathologies. However, their study usually involves invasive techniques. "A wide range of eye diseases are being investigated, but the methods for obtaining aqueous humor and vitreous humor, the fluids inside the eye, are highly invasive, which limits their applicability in routine clinical practice," explains Marta San Roque, Ph.D. student in the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) Group at the Germans Trias i Pujol Research Institute (IGTP).
Startup bets their superfast microbe can rewrite biotech
When scientists talk about velocity, they don’t usually mean bacteria. But for a small Cornell spinout called Forage Evolution, speed is everything.
The company, founded by three Cornell alumni – Bryce Brownfield, Ph.D. ’23; David Specht, Ph.D. ’21; and Cameron Kitzinger ‘22 – is betting their modified version of one of the fastest-growing microbes on Earth can upend how biologists interact with living systems. Its recent acceptance into Cornell’s Center for Life Science Ventures, the university’s incubator for promising biotech startups, marks its official leap from the lab bench into the commercial world.
Development of a Home Cancer Test Based on Human Breath Analysis Combining Canine Olfactory Capabilities and Artificial Intelligence Algorithms
Biotechnology company SpotitEarly has embarked on developing a home cancer test based on human breath analysis. The technology combines canine olfaction with artificial intelligence algorithms, reports TechCrunch.
Creating comprehensive methods for early cancer detection is key to saving the most lives. SpotitEarly CEO Shlomi Madar believes dogs can assist in this effort. He asserts that they can be trained to detect diseases, including cancer, through human scent.
World's First! Technology that measures pain from brainwaves linked with a “human augmentation platform” enables shared pain perception tailored to the recipient's experience - Pain joins movement, touch, and taste as sensations shareable via the human augmentation platform -
NTT DOCOMO, Inc. (hereinafter DOCOMO) and PaMeLa Inc. (hereinafter PaMeLa) have developed a technology (hereinafter this technology) that enables the sharing of pain sensations tailored to the individual's perception. This is achieved by integrating DOCOMO's “Human Augmentation Platform®” with PaMeLa's technology for measuring pain from brain waves, thereby estimating each person's pain sensitivity. While NTT DOCOMO's “Human Augmentation Platform” has previously enabled the sharing of actions, touch, taste, and other sensations, the development of technology to share pain tailored to the recipient's perception is a world first.
Tiny injectable antenna could power future medical implants without surgery
Scientists at the Massachusetts Institute of Technology (MIT) have created a groundbreaking antenna so small it can be injected into the body through a needle.
Despite being only about the size of a grain of sand, this new device can wirelessly power medical implants deep inside the body—potentially eliminating the need for bulky batteries or invasive surgeries.
Developed by researchers in the MIT Media Lab’s Nano-Cybernetic Biotrek group, the antenna represents a major step toward truly miniature, battery-free medical implants.
Sustainable menthol made from paper industry byproducts - Potential alternative to petroleum-based synthetic menthol
The paper manufacturing process generates significant amounts of turpentine oil, which has primarily been burned as an energy source until now. A research project at the Technical University of Cologne has developed a new method for synthesizing menthol for the pharmaceutical, food, and cosmetics industries. This could become a long-term solution to replace the petroleum-based synthetic menthol used to date.
"Turpentine oil is produced during the paper manufacturing process when wood fibers are boiled. At the headquarters of our partner UPM Kymmene alone, tens of thousands of tons are generated annually, which are currently used for thermal energy or converted into biodiesel. While exploring alternative uses, we focused on 3-carene, a chemical that makes up about 30% of the oil and can be used to produce menthol. A major challenge in this effort was separating the oil into its constituent components," explains Professor Matthias Eisenacher, project leader at the Department of Applied Natural Sciences at TH Köln.
KAIST develops wireless OLED contact lens for retinal diagnostics
The Korea Advanced Institute of Science and Technology (KAIST) has unveiled the world’s first wireless OLED contact lens designed for electroretinography (ERG). This new diagnostic tool simplifies retinal testing by eliminating bulky equipment and offers potential applications in ophthalmology, digital healthcare, and augmented reality.
Novel AI drug discovery tool predicts more accurate treatment ‘recipes’
A new AI tool has been shown to identify treatments designed to reverse disease states in cells up to 25 times quicker, more efficiently and more accurately than previous models.
Researchers from Harvard Medical School (MA, USA) have developed an AI-based graph neural network model that is able to better predict molecules that could be mediated to reverse disease states in cells and the potential drugs that could target them by considering multiple drivers of disease. PDGrapher, available for free, looks for agents that could address disease states, rather than limiting its search to agents that target molecules already known to play a role in a particular disease.
First-ever home-based digital technology approved for cardiac rehabilitation
The UK's National Institute for Health and Care Excellence (NICE) has approved six digital technologies for cardiac resynchronization (cardiac rehabilitation) for the first time.These technologies enable patients to undertake rehabilitation at home. The approved technologies are Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv, and myHeart. They provide exercise programs, education on cardiovascular disease (CVD), medication management, and psychological support. These technologies have a three-year data collection period to assess their long-term effectiveness.CVD is the second leading cause of death in the UK, affecting over 7.6 million people. While uptake of traditional cardiac rehabilitation is low, digital technologies can overcome access and scheduling barriers, particularly benefiting women, younger people, ethnic minorities, and those in economically disadvantaged areas. However, not all technologies are suitable for every patient, and assessment by healthcare professionals is required.
Resilient Life Score: Visualizing Individuals' Resilience Capabilities — Overcoming Risks from Natural Disasters and Other Societal or Personal Sources to Maintain and Enhance Well-being —
Resilient Life Score: Visualizing Individuals' Resilience Capabilities — Overcoming Risks from Natural Disasters and Social/Personal Factors to Sustain and Enhance Well-being
Hakuhodo Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kenji Nagura), Mitsubishi Research Institute, Inc. (Headquarters: Chiyoda-ku, Tokyo; President and CEO: Kenji Yabuta), and I-Resilience Inc. (Headquarters: Chuo-ku, Tokyo; President and CEO: Makoto Kobayashi) have jointly developed the “Resilient Life Score.” This score visualizes individuals' resilience capabilities, aiming to help people overcome risks stemming from natural disasters, society, and personal circumstances, thereby maintaining and enhancing their well-being.
This research outcome was developed as part of the “Resilient Life Project,” a collaborative initiative led by I-Resilience involving companies and research institutions. At the “Bousai Kokutai 2025 (10th National Disaster Prevention Promotion Convention)” held on Sunday, September 7, a workshop utilizing this score was organized for relevant stakeholders. The program provided an experiential and verification opportunity on how to collaborate with others and confront risks when facing difficulties, such as during disasters.
Japan to revolutionise Alzheimer’s Disease treatment with LIPUS-Brain Device
Japan's Sound Wave Innovation Co., Ltd. (SWI) and Sumitomo Heavy Industries, Ltd. (SHI) have announced the signing of a business alliance agreement for the manufacturing and distribution of the “LIPUS-Brain Transcranial Low-Intensity Pulsed Ultrasound Therapeutic Device”.
This strategic partnership aims to jointly promote the social implementation of this innovative medical device, targeting early-stage Alzheimer’s disease patients.
With the global increase in ageing populations, Alzheimer’s disease and other forms of dementia have become pressing societal challenges. There is a strong demand for new treatment options that are less burdensome for patients and contribute to improving the Quality of Life (QOL) for both patients and their families.
Notably, LIPUS-Brain has demonstrated high safety and showed results suggesting high efficacy in a physician-led exploratory clinical trial concluded in 2022. Following these promising results, LIPUS-Brain was designated as the first “Breakthrough Medical Device” by the Japanese Ministry of Health, Labour and Welfare (PMDA) on September 30, 2022. Subsequently, SWI began a pivotal clinical trial in October 2023.